Current strategies in radiotherapy of head and neck cancer

por Pütz, M., Wenz, F.
Publicado 2012

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

por Kripp, M., Horisberger, K., Mai, S., Kienle, P., Gaiser, T., Post, S., Wenz, F., Merx, K., Hofheinz, R.-D.
Publicado 2015

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

por Willeke, F, Horisberger, K, Kraus-Tiefenbacher, U, Wenz, F, Leitner, A, Hochhaus, A, Grobholz, R, Willer, A, Kähler, G, Post, S, Hofheinz, R-D
Publicado 2007

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer

por Chang-Claude, J, Ambrosone, C B, Lilla, C, Kropp, S, Helmbold, I, von Fournier, D, Haase, W, Sautter-Bihl, M-L, Wenz, F, Schmezer, P, Popanda, O
Publicado 2009

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer

por Sedlmayer, F., Sautter-Bihl, M.-L., Budach, W., Dunst, J., Fastner, G., Feyer, P., Fietkau, R., Haase, W., Harms, W., Souchon, R., Wenz, F., Sauer, R.
Publicado 2013

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences

por Harms, Wolfgang, Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Krug, D., Piroth, M. D., Sautter-Bihl, M.-L., Sedlmayer, F., Souchon, R., Wenz, F., Sauer, R.
Publicado 2016

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with sync...

por Budach, Wilfried, Matuschek, C., Bölke, E., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Piroth, Marc D., Sautter-Bihl, M.-L., Sedlmayer, F., Souchon, R., Wenz, F., Sauer, R.
Publicado 2015

Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin

por Popescu, R. C., Savu, D., Dorobantu, I., Vasile, B. S., Hosser, H., Boldeiu, A., Temelie, M., Straticiuc, M., Iancu, D. A., Andronescu, E., Wenz, F., Giordano, F. A., Herskind, C., Veldwijk, M. R.
Publicado 2020